This project has been flagged by a community member as inappropriate due to reason below.*
Expert Interview
Slingshot members are talking to an expert! The topic is:
Evaluation of Altimmune's Pemvidutide Phase 2b Trial for MASH
Ticker(s): ALTWho's the expert?
Institution: NYU Langone
- Adjunct Assistant Professor of Gastroenterology/Hepatology, Department of Medicine at NYU Grossman Long Island School of Medicine
- Manages 75 patients with MASH annually
- Clinical and research interest in Inflammatory Bowel Disease and Fatty Liver Disease
Interview GoalThis conversation will focus on the landscape of Metabolic Dysfunction–Associated Steatohepatitis (MASH) along with the potential of Altimmune's Pemvidutide
Are You Interested In These Questions?
Slingshot Insights Explained
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.
Reason
*Slingshot Insights provides access to information, not investment advice. We work to support you and facilitate access to experts; however we are not responsible for monitoring calls for the disclosure of MNPI. You should obtain financial, legal and tax advice from your qualified and licensed advisers before deciding to invest in any security.
